340B Health, Researchers Spar over Biosimilar Study

Maureen Testoni headshot
Maureen Testoni, president and CEO of 340B Health, traded letters to the editor of Health Affairs over a 340B study published in May.
Researchers rejected criticism of a recent study in an academic journal they co-authored from the leader of a 340B hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Transparency, Patient Assistance Requirements Needed in 340B, Say Drugmaker-Backed Groups

Justin Leventhal
Justin Leventhal, a senior policy analyst for the American Consumer Institute, has advocated for more 340B transparency alongside other drugmaker-backed groups.
Amid ongoing congressional legislative proposals to boost transparency and other requirements for 340B hospitals, two advocacy groups that receive drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital 340B Sites increased by 400% Over 11 Years, Analysis Finds

Hospital building
A consulting firm analysis found that hospital 340B covered entity and child sites increased more than fourfold over the last 11 years.
Hospital 340B covered entity and child sites increased by more than 400% over the last 11 years, while the number [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Try a Range of Responses to Manufacturer 340B Contract Pharmacy Restrictions

Colleen Meiman
Community health centers are attempting to mitigate the adverse financial effects of manufacturer 340B contract pharmacy restrictions on their organizations, said Colleen Meiman, national policy advisor for State & Regional Associations of Community Health Centers.
Amid an increasing number of drugmaker restrictions and requirements on the use of contract pharmacies, 340B providers are trying a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Incyte Becomes 26th Drugmaker to Place Contract Pharmacy Restrictions

Incyte will no longer allow 340B hospitals to have direct delivery of Opzelura products purchased at the 340B discount price to contract pharmacies.
Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHF Files Appeal Over Its Claim That Apexus Did Not Obtain Sub-Ceiling Discounts

Judge Percy Anderson
AHF appealed a ruling to dismiss by U.S. District Judge Percy Anderson over AHF's claim that Apexus did not obtain sub-ceiling discounts..
The AIDS Healthcare Foundation (AHF) recently filed an appeal to an April district court dismissal of its case against Apexus, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHIP Objects to Hospital Efforts to Target Medicare Advantage 340B ‘Windfall’

Matthew Eyles
Matthew Eyles, president and CEO of AHIP, objected to hospital-sought rules that target the Medicaid Advantage 340B "windfall."
The largest health insurer advocacy organization urged federal regulators to reject hospital-sought rules to limit the ability of Medicare Advantage [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health Centers Appeal Loss in California Medicaid Lawsuit

Michelle Baass headshot
Michelle Baass, director of the California Department of Health Care Services, was the defendant in a California Medicaid lawsuit by health centers.
California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Driving Anti-Competitive Health System Tactics, Says Lawsuit

Jefferson Health building
An independent cancer care practice filed a federal lawsuit against Jefferson Health related to the 340B program.
An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer